Acasă › Cancer pulmonar cu celule non-pătrate › Colorado › Aurora
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Aurora, CO
31 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Aurora (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- University Of Colorado - Anschutz Medical Campus /ID# 269069, Aurora
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Rocky Mountain Cancer Centers-Aurora, Aurora
- UCHealth University of Colorado Hospital, Aurora
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- University of Colorado, Aurora
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
În curs de recrutareFaza 3
- University of Colorado Anschutz Medical Campus ( Site 0151), Aurora
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
În curs de recrutareFaza 3
- University of Colorado Cancer Center ( Site 3268), Aurora
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Rocky Mountain Cancer Centers LLP, Aurora
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
În curs de recrutareFaza 1/2
- Rocky Mountain Cancer Centers,LLP, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
În curs de recrutareFaza 1/2
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- University of Colorado Cancer Center, Aurora
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
În curs de recrutareFaza 3
- Clinical Study Site, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
În curs de recrutareFaza 1/2
- University of Colorado - Aurora Cancer Center, Aurora
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Local Institution - 007-872-H, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- University of Colorado, Aurora
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
În curs de recrutareFaza 1/2
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- University of Colorado Cancer Center, Aurora
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- University of Colorado Health Hospital, Aurora
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
În curs de recrutareFaza 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
În curs de recrutareFaza 3
- University of Colorado Health, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- University of Colorado, Aurora
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
În curs de recrutareFaza 1/2
- University of Colorado Cancer Center, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- UCHealth University of Colorado Hospital, Aurora
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
În curs de recrutareStudiu observațional
- University of Colorado Hospital, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Rocky Mountain Regional VA Medical Center, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- UCHealth University of Colorado Hospital, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
În curs de recrutareFaza 1/2
- University of Colorado Cancer Center, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Rocky Mountain Cancer Centers-Aurora, Aurora
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
În curs de recrutareStudiu observațional
- University of Colorado, Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Aurora
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
În curs de recrutareStudiu observațional
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
În curs de recrutareFaza 1
- University of Colorado School of Medicine, Aurora
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Aurora
- Cancer (toate tipurile)35 studii
- Cancer colorectal32 studii
- Cancer de sân28 studii
- Cancer ovarian25 studii
- Cancer metastatic25 studii
- Diabet de tip 123 studii
- Obezitate22 studii
- Cancer de prostată19 studii
- Cancer pulmonar19 studii
- Insuficiență cardiacă18 studii
- Melanom18 studii
- Leucemie mieloasă acută16 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.